Improving Antipsychotic Adherence in Schizophrenia Using Cognitive Behavioral Therapy: Expert Interview with Peter J. Weiden, MD Medscape. Posted 06/28/2007

The Interview

The Medscape interview with Peter Weiden, MD,¹ addresses a question that has puzzled me for years: why, when there is good evidence that CBT can enhance compliance, isn’t this modality more available and more often used. Perhaps it’s as simple as the marketing of any service or merchandise. Until there is a demand for an item, few will offer it; and, until it is offered, few will request it.

In any case, the interview begins with Dr. Weiden’s poster entitled “Improving Antipsychotic Adherence in Schizophrenia: A Randomized Pilot Study of a Brief CBT [Cognitive Behavioral Therapy] Intervention” and extends to a discussion compliance problems that are especially striking in although not unique to schizophrenics, Dr. Weiden’s educational trip to England where CBT is far more commonly used, the theoretical and pragmatic issues involved with using CBT to deal with noncompliance, and more.

It’s well worth the read.

This article can be found at

Footnotes

1. Dr. Weiden is Director of the Psychosis Program, in the Department of Psychiatry, at the University of Illinois Medical Center, Chicago, Illinois [back]

• A Cognitive Therapy Approach To Weight Loss - And Patient Compliance
• Insights From CATIE About Noncompliance
• Asking About Adherence
• Inhaled Insulin - Possible Compliance Enhancement
• Selling Compliance